Skip to content

Author

Jhe-Cyuan Guo

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

PD04.04. Prognostic Significance of B7-H3 Expression in High-Risk Locally Advanced ESCC After Trimodality Therapy and Adjuvant Pembrolizumab: Post-Hoc Analysis

Esophageal Cancer: Molecular Biology/Pathology B7-H3 (CD276) is an immunoregulatory molecule and emerging therapeutic target. The prognostic value of B7-H3 expression in locally advanced esophageal squamous cell carcinoma (ESCC) treated with multimodality therapy plus adjuvant pembrolizumab was unclear. We...

Chien-Huai Chuang, Jhe-Cyuan Guo, Ta-Chen Huang et al. · 0 citations
Open access Aug 2026

S24.0.1. Integrating Anti-CTLA4 Salvage With Locoregional Therapy After Anti-PD-1 in Liver-Dominant Metastatic ESCC

Questions relevant to contemporary ESCC management will focus on how to optimally sequence therapies after failure of PD-1-base therapy in advanced or metastatic ESCC, how to incorporate liver-directed strategies for liver-dominant disease or oligoprogression, and after a favorable response to ipilimumab plus nivolumab...

Chien-Huai Chuang, Huai-Cheng Huang, Jhe-Cyuan Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.